Anti-Calpain-13 (Domain III, N-Terminal), Large Subunit antibody produced in rabbit

Name Anti-Calpain-13 (Domain III, N-Terminal), Large Subunit antibody produced in rabbit
Supplier Sigma-Aldrich
Catalog C3114
Prices $345.00
Sizes 100 µg
Host Rabbit
Clonality Polyclonal
Applications IHC IP ELISA WB
Species Reactivities Human, Rat, Mouse
Antigen synthetic peptide corresponding to domain III of the large subunit of human calpain 13
Description Rabbit Polyclonal
Gene CAPN13
Conjugate unconjugated
Supplier Page Shop

Product References

Calpains: intact and active? - Calpains: intact and active?

Johnson GV, Guttmann RP. Bioessays. 1997 Nov;19(11):1011-8.

Possible involvement of m-calpain in vascular smooth muscle cell proliferation. - Possible involvement of m-calpain in vascular smooth muscle cell proliferation.

Ariyoshi H, Okahara K, Sakon M, Kambayashi J, Kawashima S, Kawasaki T, Monden M. Arterioscler Thromb Vasc Biol. 1998 Mar;18(3):493-8.

Calpain mediates integrin-induced signaling at a point upstream of Rho family - Calpain mediates integrin-induced signaling at a point upstream of Rho family

Kulkarni S, Saido TC, Suzuki K, Fox JE. J Biol Chem. 1999 Jul 23;274(30):21265-75.

An antisense oligodeoxyribonucleotide to m-calpain mRNA inhibits myoblast fusion. - An antisense oligodeoxyribonucleotide to m-calpain mRNA inhibits myoblast fusion.

Balcerzak D, Poussard S, Brustis JJ, Elamrani N, Soriano M, Cottin P, Ducastaing A. J Cell Sci. 1995 May;108 ( Pt 5):2077-82.

The calpain-calpastatin system and cellular proliferation and differentiation in - The calpain-calpastatin system and cellular proliferation and differentiation in

Murray SS, Grisanti MS, Bentley GV, Kahn AJ, Urist MR, Murray EJ. Exp Cell Res. 1997 Jun 15;233(2):297-309.

Studies on calpain expression during differentiation of rat satellite cells in - Studies on calpain expression during differentiation of rat satellite cells in

Stockholm D, Barbaud C, Marchand S, Ammarguellat F, Barritault D, Richard I, Beckmann J, Martelly I. Exp Cell Res. 1999 Nov 1;252(2):392-400.